SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

DNA Damage Repair Deficiency Validation Study in Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-experiments-dna-damage-repair-defic
Related Entities
experiments-dna-damage-repair-deficiency-parkinsons
Metadata
slugexperiments-dna-damage-repair-deficiency-parkinsons
entity_typeexperiment
kg_node_idNone
Linked Artifacts (672)
derives_from🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#95%
mentions🔬Epigenetic reprogramming in aging neurons75%
mentions🧫Factor depletion effects on DDR focus formation in vivo70%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples70%
mentions🧫TFAM and mtDNA analysis in AKI patients70%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice70%
mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%
mentions🧫In vitro DDR reconstitution on nucleosomes70%
mentions🧫dilncRNA-mediated molecular crowding and phase separation70%
mentions🧫GWAS of plasma pTau217 in East Asian cohort70%
mentions🧫Single-cell RNA-seq analysis of mouse testes with gonadal de70%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples70%
mentions🧫TDP-43 mitochondrial invasion and DNA release via mPTP70%
mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%
mentions🧫mtROS effects on TFAM and mtDNA in HK2 cells70%
mentions🧫BDEV injection and recipient microglial transcriptome analys70%
mentions🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto70%
mentions🧫IRF1 transcriptional regulation of Nlrc5 and Ciita promoters70%
mentions🧫Epigenetic clocks association with brain aging patterns in o70%
mentions🧫cGAS/STING pathway activation by TDP-43-released mtDNA70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%
mentions🧫Proposed experiment from debate on Senolytics targeting p16/70%
mentions🧫DDR factor depletion and focus formation analysis70%
mentions🧫E2F regulation of endocycles in trophoblast giant cells70%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
mentions🧫Antiviral Therapy Trial for Parkinson's Disease70%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%
mentions🧫Genetic Risk Modifiers in DLB Phenotype70%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#70%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%
mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P70%
mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther70%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa70%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio70%
mentions🧫Cytochrome Therapeutics70%
mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 70%
mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress70%
mentions🧫Experiment: Multi-Ethnic PD GWAS70%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec70%
mentions🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#70%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and70%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%
mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%
mentions🧫Viral Infections and Alzheimer's Disease — causal mecha70%
mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧪SIRT6-NAD+ Axis Enhancement Therapy70%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🔬Epigenetic reprogramming in aging neurons67%
related🧫Factor depletion effects on DDR focus formation in vivo63%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples63%
related🧫TFAM and mtDNA analysis in AKI patients63%
related🧫Longitudinal TLR2 reporter gene study in α-synuclein mice63%
related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%
related🧫In vitro DDR reconstitution on nucleosomes63%
related🧫dilncRNA-mediated molecular crowding and phase separation63%
related🧫GWAS of plasma pTau217 in East Asian cohort63%
related🧫Single-cell RNA-seq analysis of mouse testes with gonadal de63%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples63%
related🧫TDP-43 mitochondrial invasion and DNA release via mPTP63%
related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%
related🧫mtROS effects on TFAM and mtDNA in HK2 cells63%
related🧫BDEV injection and recipient microglial transcriptome analys63%
related🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto63%
related🧫IRF1 transcriptional regulation of Nlrc5 and Ciita promoters63%
related🧫Epigenetic clocks association with brain aging patterns in o63%
related🧫cGAS/STING pathway activation by TDP-43-released mtDNA63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫s:** - Temporal analysis showing mitochondrial defects prece63%
related🧫Proposed experiment from debate on Mitochondrial transfer be63%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%
related🧫Proposed experiment from debate on Senolytics targeting p16/63%
related🧫DDR factor depletion and focus formation analysis63%
related🧫E2F regulation of endocycles in trophoblast giant cells63%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%
related🧫Antiviral Therapy Trial for Parkinson's Disease63%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT63%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise63%
related🧫Genetic Risk Modifiers in DLB Phenotype63%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#63%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P63%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther63%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise63%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa63%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio63%
related🧫Cytochrome Therapeutics63%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress63%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise63%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec63%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#63%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and63%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation63%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%
related🧫Viral Infections and Alzheimer's Disease — causal mecha63%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des63%
related🧪SIRT6-NAD+ Axis Enhancement Therapy63%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Cytochrome Therapeutics60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%
see_also📖ar60%
see_also📖ATP2A3 Gene60%
see_also📖CDK9 Gene60%
see_also📖Class II Major Histocompatibility Complex Transactivator60%
see_also📖DNMT3B Gene60%
see_also📖DUOX2 Gene60%
see_also📖ENDOG60%
see_also📖eno160%
see_also📖FANCD2 Gene60%
see_also📖FEN1 — Flap Endonuclease 160%
see_also📖FLCN Gene60%
see_also📖FOSB Gene60%
see_also📖FOXP1 Gene60%
see_also📖GADD45G — Growth Arrest And DNA Damage Inducible Gamma60%
see_also📖GNAI2 Gene60%
see_also📖GPX1 — Glutathione Peroxidase 160%
see_also📖GSTP1 — Glutathione S-Transferase Pi 160%
see_also📖HSPA9 Gene60%
see_also📖IFNAR1 — Interferon Alpha Receptor 160%
see_also📖IL33 Gene60%
see_also📖LIF — Leukemia Inhibitory Factor60%
see_also📖NBS1 (NBN)60%
see_also📖NEIL1 — Nei Endonuclease VIII-Like 160%
see_also📖NLRC5 — NLR Family CARD Domain Containing 560%
see_also📖NPM1 Gene60%
see_also📖NUCKS1 Gene60%
see_also📖OGDH — Oxoglutarate Dehydrogenase60%
see_also📖OGDHL — Oxoglutarate Dehydrogenase Like60%
see_also📖OGG1 Gene60%
see_also📖OMA1 Gene60%
see_also📖PALB2 Gene60%
see_also📖PDE10A — Phosphodiesterase 10A60%
see_also📖PDIA3 - Protein Disulfide Isomerase Family A Member 360%
see_also📖PDPK1 Gene60%
see_also📖PMS2 — DNA Mismatch Repair Protein PMS260%
see_also📖PNKP - Polynucleotide Kinase 3'-Phosphatase60%
see_also📖polg260%
see_also📖POU5F1 (Oct4) - POU Class 5 Homeobox 160%
see_also📖RAD18 Gene60%
see_also📖RAD5160%
see_also📖RAD54 Gene60%
see_also📖RCAN1 Gene60%
see_also📖RNASEH2B — Ribonuclease H2 Subunit B60%
see_also📖RPL23 Gene60%
see_also📖sf3b160%
see_also📖SMN1 - Survival Motor Neuron 160%
see_also📖SUMO2 — Small Ubiquitin-Like Modifier 260%
see_also📖TIGAR - TP53-Induced Glycolysis and Apoptosis Regulator60%
see_also📖TLR9 — Toll-Like Receptor 960%
see_also📖TMEM173 (STING)60%
see_also📖tnfaip360%
see_also📖trpv260%
see_also📖u2af160%
see_also📖UCP2 — Uncoupling Protein 260%
see_also📖WEE1 Gene60%
see_also📖XPA Gene60%
see_also📖XRCC1 Gene60%
see_also📖XRCC360%
see_also📖YBX1 Gene60%
see_also📖YWHAG Gene60%
see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%
see_also📖GSTP1 Protein (Glutathione S-Transferase Pi 1)60%
see_also📖Uncoupling Protein 2 (UCP2)60%
see_also📖wee160%
see_also📖Trehalose for Neurodegenerative Diseases60%
see_also📖acc-chronic-pain60%
see_also📖metformin-add-on-levodopa-pd-nct0705595860%
see_also📖MSH3 (Redirect)60%
see_also📖ABCG1 Gene60%
see_also📖ACTB Gene60%
see_also📖ALS10 - Amyotrophic Lateral Sclerosis 10 (TARDBP)60%
see_also📖ALS7 - Amyotrophic Lateral Sclerosis 760%
see_also📖ALS8 - Amyotrophic Lateral Sclerosis 860%
see_also📖ALS9 - Amyotrophic Lateral Sclerosis 960%
see_also📖Alsin (ALSIN)60%
see_also📖ATG16L2 Gene60%
see_also📖ATRX — Alpha Thalassemia/Mental Retardation Syndrome X-Linke60%
see_also📖BAP1 (BRCA1-Associated Protein 1)60%
see_also📖BIRC5 (Survivin)60%
see_also📖CDKN1B — Cyclin-Dependent Kinase Inhibitor 1B60%
see_also📖chmp660%
see_also📖CTSC — Cathepsin C60%
see_also📖cxcr560%
see_also📖DAO Gene60%
see_also📖DGUOK — Deoxyguanosine Kinase60%
see_also📖DLK1 Gene60%
see_also📖DNAJC6 — DnaJ Heat Shock Protein Family Member A660%
see_also📖eef1a160%
see_also📖FAN1 Gene60%
see_also📖FHL1 Gene60%
see_also📖GABARAPL1 — GABA Type A Receptor Associated Protein Like 160%
see_also📖GABRA5 Gene60%
see_also📖GRIN2B — NMDA Receptor Subunit 2B60%
see_also📖GRM3 — Glutamate Metabotropic Receptor 360%
see_also📖GRM4 Gene60%
see_also📖HTR2A Gene60%
see_also📖LINGO3 Gene60%
see_also📖LRP1B — Low Density Lipoprotein Receptor-Related Protein 1B60%
see_also📖macf160%
see_also📖MDC1 — Mediator of DNA Damage Checkpoint 160%
see_also📖MRE11 Gene60%
see_also📖MSH2 — MutS Homolog 260%
see_also📖NCAM1 Gene60%
see_also📖NCF1 — Neutrophil Cytosolic Factor 160%
see_also📖NCOR1 Gene - Nuclear Receptor Corepressor 160%
see_also📖NF2 — Merlin/Neurofibromin 260%
see_also📖PAH Gene60%
see_also📖PANK2 — Pantothenate Kinase 260%
see_also📖PLD3 Gene60%
see_also📖PLK1 Gene60%
see_also📖POMC — Proopiomelanocortin60%
see_also📖RECQL4 — RECQ DNA Helicase Like 460%
see_also📖RGS2 Gene - Regulator of G Protein Signaling 260%
see_also📖RGS4 Gene60%
see_also📖RRM2B Gene60%
see_also📖SCN5A Gene60%
see_also📖SETDB160%
see_also📖SLC25A4 Gene60%
see_also📖SUCLA2 Gene60%
see_also📖SUCLG1 — Succinate-CoA Ligase GDP Forming Subunit Alpha60%
see_also📖SYNGR1 Gene60%
see_also📖SYNJ1 — Synaptojanin 160%
see_also📖TK2 Gene60%
see_also📖TNR Gene — Tenascin R60%
see_also📖TPH2 — Tryptophan Hydroxylase 260%
see_also📖TPX260%
see_also📖TRPM2 - Transient Receptor Potential Melastatin 260%
see_also📖TWNK Gene60%
see_also📖TYMP Gene60%
see_also📖UFM1 — Ubiquitin-like Modifier 160%
see_also📖USF1 — Upstream Transcription Factor 160%
see_also📖VPS11 — Vacuolar Protein Sorting 1160%
see_also📖WRN — Werner Syndrome RecQ Like Helicase60%
see_also📖XRCC460%
see_also📖Lysosomal Dysfunction in Neurodegeneration60%
see_also📖Lysosomal Dysfunction in Progressive Supranuclear Palsy60%
see_also📖Alsin Protein (ALS2)60%
see_also📖MPV17 Protein60%
see_also📖PAH Protein60%
see_also📖RECQL4 Protein60%
see_also📖SYNJ1 Protein60%
see_also📖Thymidine Kinase 2 Protein60%
see_also📖TRPM2 (Transient Receptor Potential Melastatin 2)60%
see_also📖Thymidine Phosphorylase Protein60%
see_also📖cGAS-STING Pathway Dysregulation Hypothesis in Parkinson60%
see_also📖NEUROG1 (Neurogenin-1)60%
see_also📖CASP2 Gene60%
see_also📖RNASEH1 — Ribonuclease H160%
see_also📖Caspase 2 (CASP2)60%
see_also📖Frontotemporal Dementia (FTD)60%
see_also📖Actin Cytoskeleton Dynamics in Neurodegeneration60%
see_also📖Hepsin Protein60%
see_also📖CHCHD2 - Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containi60%
see_also📖MUTYH Gene60%
see_also📖TLR7 Gene60%
see_also📖spinal-cord60%
see_also📖SPG7 (Redirect)60%
see_also📖ACE Gene60%
see_also📖ADRA2A Gene60%
see_also📖adra2b Gene60%
see_also📖ASH1L60%
see_also📖FMN2 Gene60%
see_also📖GALNT3 — Polypeptide N-acetylgalactosaminyltransferase 360%
see_also📖HDAC8 Gene60%
see_also📖HEATR1 Gene60%
see_also📖IL16 Gene60%
see_also📖MBD2 Gene - Methyl-CpG Binding Domain Protein 260%
see_also📖MFSD2A - Major Facilitator Superfamily Domain Containing 2A60%
see_also📖MPV17 Gene - MPV17 Mitochondrial Inner Membrane Protein60%
see_also📖MSH6 — MutS Homolog 660%
see_also📖NDUFS8 — NADH:Ubiquinone Oxidoreductase Core Subunit S860%
see_also📖PRDM2 — PR/SET domain 260%
see_also📖SPG7 — Spastic Paraplegia 7 (Paraplegin)60%
see_also📖SUFU — Suppressor of Fused, Hedgehog Pathway Regulator60%
see_also📖Nucleolin Protein60%
see_also📖PRDM2 Histone Methyltransferase (PRDM2)60%
see_also📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis60%
see_also📖dopaminergic-vta-pd60%
see_also📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas60%
see_also📖Globus Pallidus Internus in Parkinsons Disease60%
see_also📖Melanocytes in Parkinson Disease60%
see_also📖Nigrostriatal Dopamine Terminals in Parkinson's Disease60%
see_also📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di60%
see_also📖Vulnerable Dopaminergic Neurons in Parkinson's Disease60%
see_also📖AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial60%
see_also📖ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's Dis60%
see_also📖Apocynin for Parkinson's Disease60%
see_also📖Bacillus Subtilis for Parkinson Disease (NCT06487975)60%
see_also📖biib122-luma-lrrk2-inhibitor-pd60%
see_also📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par60%
see_also📖CVN424 Phase 3 ARISE Trial for Parkinson's Disease60%
see_also📖Intranasal Insulin and Glutathione for PD (NOSE-PD)60%
see_also📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin60%
see_also📖nct05266417-nose-pd60%
see_also📖nct06365190-rtms-pd60%
see_also📖NCT06487975: Bacillus Subtilis Gut Microbiome Intervention f60%
see_also📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin60%
see_also📖Dyadic Mindfulness for PD Carers (NCT06821230)60%
see_also📖Amino Acid Supplement in Parkinson's Disease (NCT06954660%
see_also📖Vibrotactile Stimulation Walking Speed PD Trial60%
see_also📖Noradrenergic Arousal System Phase 3 PD Trial (NCT07316296)60%
see_also📖tDCS + Nordic Walking for Parkinson's Disease Motor Sym60%
see_also📖NouvNeu001 Cell Therapy for Parkinson's Disease60%
see_also📖PDE4 Inhibitor PD Trial60%
see_also📖Retigabine PD Trial60%
see_also📖Valacyclovir for HSV-1-Positive Parkinson's Disease60%
see_also📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x60%
see_also📖AMP-PD: Accelerating Medicines Partnership: Parkinson's60%
see_also📖Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
see_also📖Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
see_also📖Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
see_also📖Combination Therapy Sequencing in Parkinson's Disease60%
see_also📖Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%
see_also📖GLP-1 Agonist Responder Prediction Study — Precision Medicin60%
see_also📖Non-Motor Symptom Progression in Parkinson's Disease — 60%
see_also📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
see_also📖ano960%
see_also📖RBPJL — Recombination Binding Protein Lambda60%
see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%
see_also📖Accelerating Medicines Partnership for Parkinson's Dise60%
see_also📖Fibrinogen and αVβ3 Integrin in Alpha-Synuclein Pathology60%
see_also📖MLCS Quantification Methods in Parkinson's Disease Rese60%
see_also📖Pallido-Thalamocortical Motor Pathway in Parkinson's Di60%
see_also📖PDLIM7 Epigenetic Activation in Parkinson's Disease60%
see_also📖SAA and Imaging for Prodromal Parkinson's Disease Trial60%
see_also📖AI-Powered Movement Analysis for Parkinson's Disease60%
see_also📖Digital Biomarker Platforms for Parkinson's Disease60%
see_also📖Digital Therapeutics for Parkinson's Disease60%
see_also📖Wearable Sensors for Parkinson's Disease60%
see_also📖Adenosine A2A Receptor Antagonists60%
see_also📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D60%
see_also📖Neurorestore Therapies for Parkinson's Disease60%
see_also📖Synaptic Plasticity Therapeutics for Parkinson's Diseas60%
see_also📖BMI160%
see_also📖CDK12 — Cyclin-Dependent Kinase 1260%
see_also📖CTCF Gene60%
see_also📖FGFR2 — Fibroblast Growth Factor Receptor 260%
see_also📖HDAC4 Gene60%
see_also📖HEXB Gene - Hexosaminidase Beta60%
see_also📖HNRPU — Heterogeneous Nuclear Ribonucleoprotein U60%
see_also📖MAOA Gene60%
see_also📖MDM4 (MDMX)60%
see_also📖MEF2A60%
see_also📖NEK7 Gene60%
see_also📖NRAS Gene60%
see_also📖NRBP1 - Nuclear Receptor Binding Protein 160%
see_also📖PARP2 Gene60%
see_also📖PARP3 Gene60%
see_also📖PAX6 — Paired Box 660%
see_also📖PRMT560%
see_also📖RPA1 Gene60%
see_also📖SGK1 Gene60%
see_also📖slc1a560%
see_also📖stathmin60%
see_also📖TDP1 Gene60%
see_also📖TET1 Gene60%
see_also📖TNKS Gene60%
see_also📖TRIM24 — Tripartite Motif Containing 2460%
see_also📖XPF Gene60%
see_also📖xpg60%
see_also📖XPO1 Gene60%
see_also📖HDAC4 Protein60%
see_also📖PAX6 Protein60%
see_also📖stathmin60%
see_also📖Stathmin-1 Protein60%
see_also📖Stathmin-2 Protein60%
see_also📖Stathmin-2** is a protein. This page describes its structure60%
see_also📖a2m60%
see_also📖ABCD3 Gene60%
see_also📖FANCA Gene60%
see_also📖FANCC Gene60%
see_also📖fance60%
see_also📖FGF1 Gene60%
see_also📖GABRP — GABA-A Receptor Pi Subunit60%
see_also📖KIF5B Gene60%
see_also📖MYO5A — Myosin Va60%
see_also📖NLRP12 — NLR Family Pyrin Domain Containing 1260%
see_also📖npc160%
see_also📖NTN3 Gene60%
see_also📖PEN2 Gene60%
see_also📖SNRNP70 Gene60%
see_also📖SP1 (Specificity Protein 1)60%
see_also📖SP3 — Specificity Protein 360%
see_also📖TAF15 Gene60%
see_also📖Presenilin Enhancer 2 (PEN-2) Protein60%
see_also📖PEN2 Protein60%
see_also📖PEN2 Protein60%
see_also📖TRIM28 (KAP1) Protein60%
see_also📖Mitochondrial Dynamics60%
see_also📖mitochondrial-dynamics60%
see_also📖Mitochondrial Dynamics in Neurodegeneration60%
see_also📖Mitochondria60%
see_also📖ACVR2A Gene60%
see_also📖ATP2A2 Gene60%
see_also📖CSNK2A1 Gene60%
see_also📖DICER1 Gene60%
see_also📖DNAJC13 — DnaJ Heat Shock Protein Family Member C1360%
see_also📖DRAM1 Gene60%
see_also📖E2F1 Gene60%
see_also📖E2F Transcription Factor 260%
see_also📖E2F3 Gene60%
see_also📖E2F7 Gene60%
see_also📖E2F8 Gene60%
see_also📖EBF3 — Early B-cell Factor 360%
see_also📖GSTM1 (Glutathione S-Transferase Mu 1)60%
see_also📖MAP3K4 — Mitogen-Activated Protein Kinase Kinase Kinase 460%
see_also📖MST1 Gene60%
see_also📖RBPJ Gene60%
see_also📖RPA2 Gene60%
see_also📖SESN1 Gene60%
see_also📖SIRT7 Gene60%
see_also📖SUZ1260%
see_also📖UNG Gene60%
see_also📖VAPB (VAMP-Associated Protein B)60%
see_also📖Ferroportin (SLC40A1)60%
see_also📖Ferroportin60%
see_also📖GSTM1 Protein (Glutathione S-Transferase Mu 1)60%
see_also📖C21orf2 — Chromosome 21 Open Reading Frame 260%
see_also📖CHCHD10 — Coiled-Coil-Helix-Coiled-Coil-Helix Domain Contain60%
see_also📖kif2a60%
see_also📖NEK1 — NIMA Related Kinase 160%
see_also📖pcdh1560%
see_also📖PGK1 Gene60%
see_also📖PRKCI60%
see_also📖RPL27A — Ribosomal Protein L27A60%
see_also📖S100A6 Gene60%
see_also📖TPR — Translocated Promoter Region60%
see_also📖CHCHD10 Protein60%
mentions🧪Senescent Cell Mitochondrial DNA Release55%
mentions🧪Nucleolar Stress Response Normalization55%
related🧪Noradrenergic-Tau Propagation Blockade55%
related🧪Circadian-Gated Maresin Biosynthesis Amplification55%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th55%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk50%
mentions🧫NPM1-IRF1 protein interaction validation50%
mentions🧫NPM1 knockout tumor progression study in syngeneic mice50%
mentions🧫In vitro T-cell killing assay with OVA-presenting tumor cell50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%
mentions🧪Aquaporin-4 Polarization Rescue50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪Phase-Separated Organelle Targeting50%
mentions🧪RNA Granule Nucleation Site Modulation50%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Axonal RNA Transport Reconstitution50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%
mentions🧪Lysosomal Positioning Dynamics Modulation50%
mentions🧪Lysosomal Calcium Channel Modulation Therapy50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪Netrin-1 Gradient Restoration50%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
mentions🧪Autophagosome Maturation Checkpoint Control50%
mentions🧪Cryptic Exon Silencing Restoration50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
mentions🧪Cross-Seeding Prevention Strategy50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪VCP-Mediated Autophagy Enhancement50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
mentions🧪Lysosomal Membrane Repair Enhancement50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪PARP1 Inhibition Therapy40%
related🧪Lysosomal Membrane Repair Enhancement40%
related🧪Nucleolar Stress Response Normalization40%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub